(HealthDay) -- For patients with operable breast cancer, peripheral neuropathy due to adjuvant taxane therapy does not correlate with improved outcomes, according to research published online July 30 in the Journal of Clinical ...
Aug 2, 2012
0
0
Many women treated for breast cancer using taxanes, a type of cytostatic drug, often experience side effects in the nervous system. Researchers at Linköping University have developed a tool that can predict the risk level ...
Jul 9, 2024
0
39
(HealthDay) -- More than half of patients with relapsed or refractory systemic anaplastic large-cell lymphoma (ALCL) treated with the CD30-directed antibody-drug conjugate brentuximab vedotin achieve a complete remission, ...
May 24, 2012
0
0
New research in JNCCN—Journal of the National Comprehensive Cancer Network suggests that patients who have insufficient levels of vitamin D before starting paclitaxel treatment are more likely to experience peripheral neuropathy.
Nov 7, 2023
0
3
Medicine should reconsider how it treats stroke and other neurological disorders, focusing on the intrinsic abilities of the brain and nervous system to heal themselves rather than the "modest" benefits of clot-busting drugs ...
Mar 2, 2015
0
7
While the pace of research on the novel coronavirus has been impressively rapid, there remains a lot we still don't know about the wily pathogen. One of those unknowns is the potential long-term health implications for people ...
Jun 12, 2020
0
3
(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency said Tuesday in a news ...
Mar 21, 2018
0
4
A study published in the American Journal of Managed Care states that the number of patients requiring first-line chemotherapy is expected to increase by more than 50%, from 9.8 million to 15 million, from 2018 to 2040.
Dec 3, 2019
0
15
Researchers at Moffitt Cancer Center and colleagues have investigated the safety, efficacy and the maximum tolerated dose of pomalidomide for patients with multiple myeloma who have disease relapsed after treatments with ...
Jan 24, 2013
0
0
Consuming too much folate (vitamin B9) is associated with increased risk for a nerve-damage disorder in older adults who have a common genetic variant. Although variable by race or ethnic background, an estimated one in six ...
Oct 12, 2016
0
1
